TY - JOUR
T1 - Intraperitoneal chemotherapy for women with epithelial ovarian cancer
AU - Trimble, Edward L.
AU - Thompson, Sharon
AU - Christian, Michaele C.
AU - Minasian, Lori
PY - 2008/4
Y1 - 2008/4
N2 - In 2006, i.p. chemotherapy re-emerged as a controversial topic in debates about the optimal treatment for women with advanced epithelial ovarian cancer. In this paper, we address the rationale behind i.p. chemotherapy, the data supporting its use, the selection of appropriate patients for i.p. chemotherapy, how best to avoid and manage the toxicities observed with i.p. chemotherapy, and directions for future research.
AB - In 2006, i.p. chemotherapy re-emerged as a controversial topic in debates about the optimal treatment for women with advanced epithelial ovarian cancer. In this paper, we address the rationale behind i.p. chemotherapy, the data supporting its use, the selection of appropriate patients for i.p. chemotherapy, how best to avoid and manage the toxicities observed with i.p. chemotherapy, and directions for future research.
UR - http://www.scopus.com/inward/record.url?scp=43549085283&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=43549085283&partnerID=8YFLogxK
U2 - 10.1634/theoncologist.2007-0058
DO - 10.1634/theoncologist.2007-0058
M3 - Review article
C2 - 18448554
AN - SCOPUS:43549085283
SN - 1083-7159
VL - 13
SP - 403
EP - 409
JO - Oncologist
JF - Oncologist
IS - 4
ER -